SCHEMBL1126865

SCHEMBL1126865

CSCn1c(C)c(C(=O)O)c(-c2ccccc2)c1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 3/20 0.44
GRIA4 P48058 4/20 0.41
GRIA2 P42262 3/20 0.41
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TSHR P16473 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
POLB P06746 2/20 0.38
HPGD P15428 2/20 0.38
KLK1 P06870 1/20 0.36
PTGS2 P35354 1/20 0.36
NPC1 O15118 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1127239 0.87 AR (0.42) ARGRIA4GRIA2LMNASMN1; SMN2
SCHEMBL1988958 0.85 KDM4E (0.49) ARGRIA4GRIA2LMNASMN1; SMN2
SCHEMBL1126637 0.82 AR (0.60) ARLMNASMN1; SMN2TSHRMEN1
SCHEMBL1127427 0.82 KDM4E (0.45) ARGRIA4GRIA2LMNASMN1; SMN2
SCHEMBL1127403 0.80 MEN1 (0.49) ARGRIA4GRIA2TSHRMEN1
SCHEMBL15162395 0.80 TSHR (0.53) ARGRIA4GRIA2LMNASMN1; SMN2
SCHEMBL1126615 0.80 TSHR (0.53) ARLMNASMN1; SMN2TSHRMEN1
SCHEMBL1127384 0.79 AR (0.46) ARGRIA4GRIA2LMNATSHR
SCHEMBL1126762 0.79 AR (0.43) ARGRIA4GRIA2LMNASMN1; SMN2
SCHEMBL15161954 0.79 PTGDR2 (0.50) ARSMN1; SMN2TSHRKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9452168-B2 Pyrrole antifungal agents F2G LTD (GB) 2016-09-27 US disclosed
US-20150238500-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2015-08-27 US disclosed
EP-2283006-B1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2015-02-25 EP disclosed
EP-2626361-B1 Pyrrole antifungal agents F2G LTD (GB) 2014-10-15 EP disclosed
EP-2626361-A1 Pyrrole antifungal agents F2G Limited (GB) 2013-08-14 EP disclosed
EP-2283006-A1 PYRROLE ANTIFUNGAL AGENTS F2G Limited (GB) 2011-02-16 EP disclosed
WO-2009130481-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2009-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150238500-A1 PYRROLE ANTIFUNGAL AGENTS FOXM1, PYCR1, ARG1 AR 2125/4885GRIA4 2979/4885GRIA2 2791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.